Edwards Lifesciences Corp’s recently made public that its CVP, JAPAC Lippis Daniel J. unloaded Company’s shares for reported $0.19 million on Dec 16 ’24. In the deal valued at $74.08 per share,2,500 shares were sold. As a result of this transaction, Lippis Daniel J. now holds 23,189 shares worth roughly $1.71 million.
Then, Lippis Daniel J. bought 2,500 shares, generating $185,196 in total proceeds.
Before that, Ullem Scott B. sold 11,250 shares. Edwards Lifesciences Corp shares valued at $806,406 were divested by the CVP, Chief Financial Officer at a price of $71.68 per share. As a result of the transaction, Ullem Scott B. now holds 30,561 shares, worth roughly $2.25 million.
BofA Securities upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Neutral in a research note published recently. Jefferies also remained covering EW and has decreased its forecast on September 18, 2024 with a “Hold” recommendation from previously “Buy” rating. Daiwa Securities revised its rating on July 31, 2024. It rated EW as “an Outperform” which previously was an “a Neutral”.
Price Performance Review of EW
On Monday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -0.50% to $73.54. Over the last five days, the stock has lost -2.79%. Edwards Lifesciences Corp shares have fallen nearly -0.66% since the year began. Nevertheless, the stocks have risen 0.03% over the past one year. While a 52-week high of $96.12 was reached on 01/02/25, a 52-week low of $58.93 was recorded on 01/02/25. SMA at 50 days reached $70.91, while 200 days put it at $77.47.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 73.04, which if violated will result in even more drops to 72.53. On the upside, there is a resistance level at 74.19. A further resistance level may holdings at 74.83. The Relative Strength Index (RSI) on the 14-day chart is 52.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.15%. Stochastics %K at 32.32% indicates the stock is a holding.
How much short interest is there in Edwards Lifesciences Corp?
A steep rise in short interest was recorded in Edwards Lifesciences Corp stocks on 2024-12-13, growing by 0.43 million shares to a total of 7.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.87 million shares. There was a rise of 5.93%, which implies that there is a positive sentiment for the stock.
